The pur protein family: Genetic and structural features in development and disease

Journal of Cellular Physiology

Volumn 228, Issue 5, 2013, Pages 930-937

  Johnson, Edward M ^a   Daniel, Dianne C ^a   Gordon, Jennifer ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; PUR PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; BONE MARROW CELL; CELL AGING; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CRYSTAL STRUCTURE; DENDRITE; DNA STRAND; EUKARYOTE; FRAGILE X SYNDROME; GENE CONTROL; GENE INACTIVATION; GENE MUTATION; HUMAN; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; FRAGILE X SYNDROME; GENE KNOCKOUT TECHNIQUES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUSCLE DEVELOPMENT; NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84873825022     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24237     Document Type: Article

References (120)

1. Adelaide J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Borresen-Dale AL, Lidereau R, Birnbaum D, Pebusque MJ. 1998. Chromosome region 8p11-p21: Refined mapping and molecular alterations in breast cancer. Genes Chromosomes Cancer 22:186-199.
2. Aggarwal M, Sommers JA, Shoemaker RH, Brosh RM Jr. 2011. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress. Proc Natl Acad Sci USA 108:1525-1530.
3. Aumiller V, Graebsch A, Kremmer E, Niessing D, Forstemann K. 2012. Drosophila Pur-alpha binds to trinucleotide-repeat containing cellular RNAs and translocates to the early oocyte. RNA Biol 9.
4. Bai Y, Murnane JP. 2003. Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein. Hum Genet 113:337-347.
5. Barr SM, Johnson EM. 2001. Ras-induced colony formation and anchorage-independent growth inhibited by elevated expression of Puralpha in NIH3T3 cells. J Cell Biochem 81:621-638.
6. Bergemann AD, Johnson EM. 1992. The HeLa Pur factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication. Mol Cell Biol 12:1257-1265.
7. Bergemann AD, Ma Z-W. and Johnson E. M. 1992. Sequence of cDNA comprising the human pur gene and sequence-specific single-stranded-DNA-binding properties of the encoded protein. Mol Cell Biol 12:5673-5682.
8. Brizard A, Guilhot F, Huret JL, Benz-Lemoine E, Tanzer J. 1988. The 8p11 anomaly in "monoblastic" leukaemia. Leuk Res 12:693-697.
9. Brosh RM Jr, Opresko PL, Bohr VA. 2006. Enzymatic mechanism of the WRN helicase/nuclease. Methods Enzymol 409:52-85.
10. Carlini LE, Getz MJ, Strauch AR, Kelm RJ Jr. 2001. Cryptic MCAT enhancer regulation in fibroblasts and smooth muscle cells: Suppression of TEF-1 mediated activation by the single-stranded DNA-binding proteins, Pur{alpha}, Pur{beta}, and MSY1. J Biol Chem 21:21.
11. Chen NN, Khalili K. 1995. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. J Virol 69:5843-5848.
12. Chen N, Onisko B, Napoli J. L. 2008. The nuclear transcription factor RARalpha associates with neuronal RNA granules and suppresses translation. J Biol Chem 283:20841-20847.
13. Chen NN, Chang C-F, Gallia GL, Kerr DA, Johnson EM, Krachmarov CP, Barr SM, Frisque RJ, Bollag B. Khalili K. 1995. Cooperative action of cellular proteins YB-1 and Purα with the tumor antigen of the human JC polymovirus determines their interaction with the viral lytic control element. ProcNatl Acad Sci USA 92:1087-1091.
14. Chepenik LG, Tretiakova AP, Krachmarov CP, Johnson EM, Khalili K. 1998. The single-stranded DNA binding protein, Pur-alpha, binds HIV-1 TAR RNA and activates HIV-1 transcription. Gene 210:37-44.
15. Daniel DC, Wortman MJ, Schiller RJ, Liu H, Gan L, Mellen JS, Chang CF, Gallia GL, Rappaport J, Khalili K, Johnson EM. 2001. Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin. J Gen Virol 82:1543-1553.
16. Daniel DC, Kinoshita Y, Khan MA, Del Valle L, Khalili K, Rappaport J, Johnson EM. 2004. Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol 23:858-867.
17. Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K. 1999. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1. Oncogene 18:6398-6402.
18. Darbinian N, Gallia GL, King J, Del Valle L, Johnson EM. Khalili K. 2001a. Growth inhibition of glioblastoma cells by human Pur(alpha). J Cell Physiol 189:334-340.
19. Darbinian N, Sawaya BE, Khalili K, Jaffe N, Wortman B, Giordano A, Amini S. 2001b. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells. J Neuroimmunol 121:3-11.
20. Darbinian N, Gallia GL. Khalili K. 2001c. Helix-destabilizing properties of the human single-stranded DNA- and RNA-binding protein Puralpha. J Cell Biochem 80:589-595.
21. Darbinian N, White MK, Gallia GL, Amini S, Rappaport J, Khalili K. 2004. Interaction between the pura and E2F-1 transcription factors. Anticancer Res 24:2585-2594.
22. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB. 2001. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107:489-499.
23. Darnell JC, Fraser CE, Mostovetsky O, Darnell RB. 2009. Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs. Hum Mol Genet 18:3164-3177.
24. David JJ, Subramanian SV, Zhang A, Willis WL, Kelm RJ Jr, Leier CV, Strauch AR. 2012. Y-box binding protein-1 implicated in translational control of fetal myocardial gene expression after cardiac transplant. Exp Biol Med (Maywood) 237:593-607.
25. Dib A, Adelaide J, Chaffanet M, Imbert A, Le Paslier D, Jacquemier J, Gaudray P, Theillet C, Birnbaum D, Pebusque MJ. 1995. Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma. Oncogene 10:995-1001.
26. Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. 2008. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell 14:926-939.
27. Duning K, Buck F, Barnekow A, Kremerskothen J. 2008. SYNCRIP, a component of dendritically localized mRNPs, binds to the translation regulator BC200 RNA. J Neurochem 105:351-359.
28. Ellis NA. 1997. DNA helicases in inherited human disorders. Curr Opin Genet Dev 7:354-363.
29. Gallia GL, Safak M, Khalili K. 1998. Interaction of the single-stranded DNA-binding protein Puralpha with the human polyomavirus JC virus early protein T-antigen. J Biol Chem 273:32662-32669.
30. Gallia GL, Darbinian N, Johnson EM, Khalili K. 1999a. Self-association of Puralpha is mediated by RNA. J Cell Biochem 74:334-348.
31. Gallia GL, Darbinian N, Tretiakova A, Ansari SA, Rappaport J, Brady J, Wortman MJ, Johnson EM, Khalili K. 1999b. Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proc Natl Acad Sci USA 96:11572-11577.
32. Gallia GL, Johnson EM, Khalili K. 2000. Survey and Summary: Puralpha: A multifunctional single-stranded DNA- and RNA-binding protein. Nucleic Acids Res 28:3197-3205.
33. Gallia GL, Darbinian N, Jaffe N, Khalili K. 2001. Single-stranded nucleic acid-binding protein, Pur alpha, interacts with RNA homologous to 18S ribosomal RNA and inhibits translation in vitro. J Cell Biochem 83:355-363.
34. Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C. 2005. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 24:5235-5245.
35. Garcia-Arocena D, Hagerman PJ. 2010. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 19:R83-R89.
36. Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyries S, Adelaide J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C, Chaffanet M. 2005. Comprehensive profiling of 8p 11-12. amplification in breast cancer. Mol Cancer Res 3:655-667.
37. Gerritsen WR, Donohue J, Bauman J, Jhanwar SC, Kernan NA, Castro-Malaspina H, O'Reilly RJ, Bourhis JH. 1992. Clonal analysis of myelodysplastic syndrome: Monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 80:217-224.
38. Graebsch A, Roche S, Niessing D. 2009. X-ray structure of Pur-{alpha} reveals a Whirly-like fold and an unusual nucleic-acid binding surface. Proc Natl Acad Sci USA 106:18521-18526.
39. Graebsch A, Roche S, Kostrewa D, Soding J, Niessing D. 2010. Of bits and bugs-on the use of bioinformatics and a bacterial crystal structure to solve a eukaryotic repeat-protein structure. PLoS One 5:e13402.
40. Haas S, Gordon J, Khalili K. 1993. A developmentally regulated DNA-binding protein from mouse brain stimulates myelin basic protein gene expression. Mol Cell Biol 13:3103-31012.
41. Hokkanen S, Feldmann HM, Ding H, Jung CK, Bojarski L, Renner-Muller I, Schuller U, Kretzschmar H, Wolf E, Herms J. 2012. Lack of Pur-alpha alters postnatal brain development and causes megalencephaly. Hum Mol Genet 21:473-484.
42. Huang S, Beresten S, Li B, Oshima J, Ellis NA, Campisi J. 2000. Characterization of the human and mouse WRN 3'->5' exonuclease. Nucleic Acids Res 28:2396-2405.
43. Iacoangeli A, Rozhdestvensky TS, Dolzhanskaya N, Tournier B, Schutt J, Brosius J, Denman RB, Khandjian EW, Kindler S, Tiedge H. 2008. On BC1 RNA and the fragile X mental retardation protein. Proc Natl Acad Sci USA 105:734-739.
44. Jackson CC, Medeiros LJ, Miranda RN. 2010. 8p11 myeloproliferative syndrome: A review. Hum Pathol 41:461-476.
45. Jin P, Zarnescu DC, Zhang F, Pearson CE, Lucchesi JC, Moses K, Warren ST. 2003. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39:739-747.
46. Jin P, Duan R, Qurashi A, Qin Y, Tian D, Rosser TC, Liu H, Feng Y, Warren ST. 2007. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a drosophila model of fragile X tremor/ataxia syndrome. Neuron 55:556-564.
47. Johnson EM. 2003. The Pur protein family: Clues to function from recent studies on cancer and AIDS. Anticancer Res 23:2093-2100.
48. Johnson EM, Chen PL, Krachmarov CP, Barr SM, Kanovsky M, Ma ZW, Lee WH. 1995. Association of human Pur alpha with the retinoblastoma protein, Rb, regulates binding to the single-stranded DNA Pur alpha recognition element. J Biol Chem 270:24352-24360.
49. Johnson EM, Kinoshita Y, Weinreb DB, Wortman MJ, Simon R, Khalili K, Winckler B, Gordon J. 2006. Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J Neurosci Res 83:929-943.
50. Kaminski R, Darbinian N, Sawaya BE, Slonina D, Amini S, Johnson EM, Rappaport J, Khalili K, Darbinyan A. 2008. Puralpha as a cellular co-factor of Rev/RRE-mediated expression of HIV-1 intron-containing mRNA. J Cell Biochem 103:1231-1245.
51. Kaminski R, Cheeseboro L, Amini S, Johnson EM, White MK, Khalili K, Darbinyan A. 2010. Role of Puralpha in the cellular response to ultraviolet-C radiation. Cell Cycle 9:9.
52. Kanai Y, Dohmae N, Hirokawa N. 2004. Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule. Neuron 43:513-525.
53. Keene SE, Telesnitsky A. 2012. Cis-acting determinants of 7SL RNA packaging by HIV-1. J Virol.
54. Kelm JRJ, Elder PK, Strauch AR, Getz MJ. 1997. Sequence of cDNAs encoding components of vascular actin single-stranded DNA-binding factor 2 establish identity to Purα and Purβ. J Biol Chem 272:26727-26733.
55. Kelm RJ Jr, Cogan JG, Elder PK, Strauch AR, Getz MJ. 1999. Molecular interactions between single-stranded DNA-binding proteins associated with an essential MCAT element in the mouse smooth muscle alpha-actin promoter. J Biol Chem 274:14238-14245.
56. Khalili K, Del Valle L, Muralidharan V, Gault WJ, Darbinian N, Otte J, Meier E, Johnson EM, Daniel DC, Kinoshita Y, Amini S. Gordon J. 2003. Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol 23:6857-6875.
57. Kibbelaar RE, Mulder JW, Dreef EJ, van Kamp H, Fibbe WE, Wessels JW, Beverstock GC, Haak HL, Kluin PM. 1993. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: A comparison of banding and fluorescence in situ hybridization. Blood 82:904-913.
58. Knapp AM, Ramsey JE, Wang SX, Godburn KE, Strauch AR, Kelm RJ Jr. 2006. Nucleoprotein interactions governing cell type-dependent repression of the mouse smooth muscle alpha-actin promoter by single-stranded DNA-binding proteins Pur alpha and Pur beta. J Biol Chem 281:7907-7918.
59. Kobayashi S, Agui K, Kamo S, Li Y, Anzai K. 2000. Neural BC1 RNA associates with pur alpha, a single-stranded DNA and RNA binding protein, which is involved in the transcription of the BC1 RNA gene [In Process Citation]. Biochem Biophys Res Commun 277:341-347.
60. Kobayashi Y, Suzuki K, Kobayashi H, Ohashi S, Koike K, Macchi P, Kiebler M, Anzai K. 2008. C9orf10 protein, a novel protein component of Puralpha-containing mRNA-protein particles (Puralpha-mRNPs): Characterization of developmental and regional expressions in the mouse brain. J Histochem Cytochem 56:723-731.
61. Krachmarov CP, Chepenik LG, Barr-Vagell S, Khalili K, Johnson EM. 1996. Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. Proc Natl Acad Sci USA 93:14112-14117.
62. Laud PR, Multani AS, Bailey SM, Wu L, Ma J, Kingsley C, Lebel M, Pathak S, DePinho RA, Chang S. 2005. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev 19:2560-2570.
63. Le Beau MM. 1992. Deletions of chromosome 5 in malignant myeloid disorders. Cancer Surv 15:143-159.
64. Levenga J, Buijsen RA, Rife M, Moine H, Nelson DL, Oostra BA, Willemsen R, de Vrij FM. 2009. Ultrastructural analysis of the functional domains in FMRP using primary hippocampal mouse neurons. Neurobiol Dis 35:241-250.
65. Lezon-Geyda K, Najfeld V, Johnson EM. 1997. The PURA gene, encoding the single-stranded-DNA-binding protein Purα, as a marker for 5q31 alteration in myeloproliferative disorders, a potential early step in induction of AML. FASEB 11:A100.
66. Lezon-Geyda K, Najfeld V, Johnson EM. 2001. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Leukemia 15:954-962.
67. Li Y, Koike K, Ohashi S, Funakoshi T, Tadano M, Kobayashi S, Anzai K, Shibata N, Kobayashi M. 2001. Pur alpha protein implicated in dendritic RNA transport interacts with ribosomes in neuronal cytoplasm. Biol Pharm Bull 24:231-235.
68. Li B, Jog SP, Reddy S, Comai L. 2008. WRN controls formation of extrachromosomal telomeric circles and is required for TRF2DeltaB-mediated telomere shortening. Mol Cell Biol 28:1892-1904.
69. Liapis K, Kousiafes D, Papanikolaou A, Pagratis P, Kokkini G. 2011. The 8p11 myeloid and lymphoid neoplasm. Eur J Haematol 87:471-472.
70. Liu H, Johnson EM. 2002. Distinct proteins encoded by alternative transcripts of the PURG gene, located contrapodal to WRN on chromosome 8, determined by differential termination/polyadenylation. Nucleic Acids Res 30:2417-2426.
71. Liu H, Barr SM, Chu C, Kohtz DS, Kinoshita Y, Johnson EM. 2005. Functional interaction of Puralpha with the Cdk2 moiety of cyclin A/Cdk2. Biochem Biophys Res Commun 328:851-857.
72. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, Jaenisch R, Guarente L. 2000. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 20:3286-3291.
73. Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Benito R, del Rey J, Miro R, Roldan R, Barbera J. 2006. Primary glioblastoma with EGFR amplification and a ring chromosome 7 in a young patient. Clin Neuropathol 25:193-199.
74. Ma Z-W, Bergemann AD, Johnson EM. 1994. Conservation in human and mouse Purα of a motif common to several proteins involved in initiation of DNA replication. Gene 149:311-314.
75. Ma ZW, Pejovic T, Najfeld V, Ward DC, Johnson EM. 1995. Localization of PURA, the gene encoding the sequence-specific single-stranded-DNA-binding protein Pur alpha, to chromosome band 5q31. Cytogenet Cell Genet 71:64-67.
76. Miller S, Rogers HA, Lyon P, Rand V, Adamowicz-Brice M, Clifford SC, Hayden JT, Dyer S, Pfister S, Korshunov A, Brundler MA, Lowe J, Coyle B, Grundy RG. 2011. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma. Neuro Oncol 13:866-879.
77. Mishra M, Del Valle L, Otte J, Darbinian N, Gordon J. 2012. Pur-alpha regulates the developmental expression of RhoA and affects its downstream signaling ability in the mouse brain. J Cell Physiol.
78. Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G. 2006. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24:5223-5233.
79. Moser MJ, Kamath-Loeb AS, Jacob JE, Bennett SE, Oshima J, Monnat RJ Jr. 2000. WRN helicase expression in Werner syndrome cell lines. Nucleic Acids Res 28:648-654.
80. Muslimov IA, Iacoangeli A, Brosius J. and Tiedge H. 2006. Spatial codes in dendritic BC1 RNA. J Cell Biol 175:427-439.
81. Nagarajan L, Zavadil J, Claxton D, Lu X, Fairman J, Warrington JA, Wasmuth JJ, Chinault AC, Sever CE, Slovak ML, et al. 1994. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome. Blood 83:199-208.
82. Ohashi S, Koike K, Omori A, Ichinose S, Ohara S, Kobayashi S, Sato TA, Anzai K. 2002. Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J Biol Chem 277:37804-37810.
83. Orren DK, Theodore S, Machwe A. 2002. The Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro. Biochemistry 41:13483-13488.
84. Qurashi A, Li W, Zhou JY, Peng J, Jin P. 2011. Nuclear accumulation of stress response mRNAs contributes to the neurodegeneration caused by Fragile X premutation rCGG repeats. PLoS Genet 7:e1002102.
85. Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA, Ethier SP. 2004. Genomic and expression analysis of the 8p 11-12. Amplicon in human breast cancer cell lines. Cancer Res 64:40-47.
86. Ripperger T, Tauscher M, Praulich I, Pabst B, Teigler-Schlegel A, Yeoh A, Gohring G, Schlegelberger B, Flotho C, Niemeyer CM, Steinemann D. 2011. Constitutional trisomy 8p11.21-q11.21 mosaicism: A germline alteration predisposing to myeloid leukaemia. Br J Haematol 155:209-217.
87. Rumora AE, Steere AN, Ramsey JE, Knapp AM, Ballif BA, Kelm RJ Jr. 2010. Isolation and characterization of the core single-stranded DNA-binding domain of purine-rich element binding protein B (Purbeta). Biochem Biophys Res Commun 400:340-345.
88. Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S, Haferlach T. 2005. Genomic gains and losses influence expression levels of genes located within the affected regions: A study on acute myeloid leukemias with trisomy 8: Or 13, monosomy 7, or deletion 5q. Leukemia 19:1224-12228.
89. Schonberg S, Niermeijer MF, Bootsma D, Henderson E, German J. 1984. Werner's syndrome: Proliferation in vitro of clones of cells bearing chromosome translocations. Am J Hum Genet 36:387-397.
90. Shan SO, Walter P. 2005. Co-translational protein targeting by the signal recognition particle. FEBS Lett 579:921-926.
91. Sharma S, Otterlei M, Sommers JA, Driscoll HC, Dianov GL, Kao HI, Bambara RA, Brosh RM Jr. 2004. WRN helicase and FEN-1 form a complex upon replication arrest and together process branchmigrating DNA structures associated with the replication fork. Mol Biol Cell 15:734-750.
92. Shelley CS, Teodoridis JM, Park H, Farokhzad OC, Bottinger EP, Arnaout MA. 2002. During differentiation of the monocytic cell line U937, Pur alpha mediates induction of the CD11c beta 2 integrin gene promoter. J Immunol 168:3887-3893.
93. Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ. 2011. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 6:e26203.
94. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. 1993. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53:1217-1228.
95. Snow K, Tester DJ, Kruckeberg KE, Schaid DJ, Thibodeau SN. 1994. Sequence analysis of the fragile X trinucleotide repeat: Implications for the origin of the fragile X mutation. Hum Mol Genet 3:1543-1551.
96. Stacey DW, Hitomi M, Kanovsky M, Gan L, Johnson EM. 1999. Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pur alpha. Oncogene 18:4254-4261.
97. Swanson MS, Orr HT. 2007. Fragile X tremor/ataxia syndrome: Blame the messenger! Neuron 55:535-537.
98. Tafuri SR, Familari M, Wolffe AP. 1993. A mouse Y box protein, MSY1, is associated with paternal mRNA in spermatocytes. J Biol Chem 268:12213-12220.
99. Tan H, Qurashi A, Poidevin M, Nelson DL, Li H, Jin P. 2012. Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration. Hum Mol Genet 21:57-65.
100. Tefferi A, Mathew P, Noel P. 1994. The 5q- syndrome: A scientific and clinical update. Leuk Lymphoma 14:375-378.
101. Tiedge H, Fremeau RT Jr, Weinstock PH, Arancio O, Brosius J. 1991. Dendritic location of neural BC1 RNA. Proc Natl Acad Sci USA 88:2093-2097.
102. Tiedge H, Chen W, Brosius J. 1993. Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J Neurosci 13:2382-2390.
103. Tindall EA, Severi G, Hoang HN, Ma CS, Fernandez P, Southey MC, English DR, Hopper JL, Heyns CF, Tangye SG, Giles GG, Hayes VM. 2010. Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk. Carcinogenesis 31:1748-1754.
104. Tretiakova A, Gallia GL, Shcherbik N, Jameson B, Johnson EM, Amini S, Khalili K. 1998. Association of Puralpha with RNAs homologous to 7 SL determines its binding ability to the myelin basic protein promoter DNA sequence. J Biol Chem 273:22241-22247.
105. Tretiakova A, Steplewski A, Johnson EM, Khalili K, Amini S. 1999. Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: Evidence for association of Sp1 and Puralpha in brain. J Cell Physiol 181:160-168.
106. Ullu E, Tschudi C. 1984. Alu sequences are processed 7SL RNA genes. Nature 312:171-172.
107. Van den Berghe H, David R, Michaux JL, Sokal G, Verwilghen R. 1976. 5q-Acute myelogenous leukemia. Blood 48:624-626.
108. Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G. 1985. The 5q-anomaly. Cancer Genet Cytogenet 17:189-255.
109. Verkerk AJMH, Pieretti M, Sutcliffe JS, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen GB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warran ST. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
110. Walter P, Blobel G. 1982. Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum. Nature 299:691-698.
111. Wang H, Wang M, Reiss K, Darbinian-Sarkissian HN, Johnson EM, Iliakis G, Amini S, Khalili K, Rappaport J. 2007. Evidence for the involvement of Puralpha in response to DNA replication stress. Cancer Biol Ther 6:6.
112. Wang H, White MK, Kaminski R, Darbinian N, Amini S, Johnson EM, Khalili K, Rappaport J. 2008. Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat. Anticancer Res 28:1441-1447.
113. Washington LT, Jilani I, Estey E, Albitar M. 2002. Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia. Leuk Res 26:899-902.
114. White MK, Johnson EM, Khalili K. 2009. Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle 8:1-7.
115. Wohrle D, Hennig I, Vogel W, Steinbach P. 1993. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet 4:140-142.
116. Wortman MJ, Johnson EM, Bergemann AD. 2005. Mechanism of DNA binding and localized strand separation by Pur alpha and comparison with Pur family member, Pur beta. Biochim Biophys Acta 1743:64-78.
117. Yang Q, Zhang R, Wang XW, Spillare EA, Linke SP, Subramanian D, Griffith JD, Li JL, Hickson ID, Shen JC, Loeb LA, Mazur SJ, Appella E, Brosh RM Jr, Karmakar P, Bohr VA, Harris CC. 2002. The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J Biol Chem 277:31980-31987.
118. Yang ZQ, Liu G, Bollig-Fischer A, Giroux CN, Ethier SP. 2010. Transforming properties of 8p11-12. amplified genes in human breast cancer. Cancer Res 70:8487-8497.
119. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD. 1996. Positional cloning of the Werner's syndrome gene. Science 272:258-262.
120. Zhang A, David JJ, Subramanian SV, Liu X, Fuerst MD, Zhao X, Leier CV, Orosz CG, Kelm RJ Jr, Strauch AR. 2008. Serum response factor neutralizes Pur alpha- and Pur beta-mediated repression of the fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes. Am J Physiol Cell Physiol 294:C702-C714.